Bu sayfada
ADMA ADMA Biologics Inc - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$9,72
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$7,2152 haftanın en düşüğü
$20,4652 haftanın en yükseği
Piyasa Değeri (MRQ)
$2.19B
P/E (TTM)
13.9
Hisse Başına Kâr (TTM)
$0.70
Gelir (TTM)
$512M
rozetleriniz
52 Haftlık Aralık
$7–$20
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$17
P/E
13.9
ROE
41.9%
Net Kâr Marjı
33.0%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ADMA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$9.72
Piyasa Değeri (MRQ)
$2.19B
P/E (TTM)
13.9
Hisse Başına Kâr (TTM)
$0.70
Gelir (TTM)
$512M
ROE (TTM)
41.9%
D/E Borç/Özsermaye (MRQ)
0.5
52 Haftlık Aralık
$7–$20
ADMA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
ADMA Biologics Inc - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriBiotechnology
çalışanlar640
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$510M2023-12-31 → 2025-12-31
Hisse Başına Kâr$0.602023-12-31 → 2025-12-31
Serbest Nakit Akışı$28M2023-12-31 → 2025-12-31
Net kar marjı33.0%2023-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ADMA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 13.9 | · | · | · | |
| F/S (TTM) | 4.3 | · | 29.2 | Düşük değerli | |
| F/D (MRQ) | 5.4 | · | 5.4 | Adil değer | |
| EV / EBITDA | 11.5 | · | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | 18.8 | · | · | · | |
| Fiyat / Nakit Akışı (TTM) | 16.0 | · | · | · | |
| EV / Revenue (EV / Gelir) | 4.5 | · | · | · | |
| EV / FCF | 82.6 | · | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 5.4 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ADMA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 64.7% | · | · | · | |
| Faaliyet Kâr Marjı (TTM) | 43.8% | · | -1089.3% | En üst düzey | |
| FAVÖK Marjı (TTM) | 45.3% | · | -1089.3% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | 42.3% | · | -553.3% | En üst düzey | |
| Net Kâr Marjı (TTM) | 33.0% | · | -1113.0% | En üst düzey | |
| ROA (TTM) | 27.2% | · | -42.4% | En üst düzey | |
| ROE (TTM) | 41.9% | · | -59.4% | En üst düzey | |
| ROIC | 28.0% | · | -88.3% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ADMA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.5 | · | 0.0 | Yüksek borç | |
| Cari Oran (MRQ) | 7.0 | · | 8.5 | Ortalamanın altında | |
| Quick Ratio (Cari Oran) | 3.5 | · | 5.9 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 0.5 | · | 0.2 | Yüksek borç |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ADMA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 19.6% | · | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 49.0% | · | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 64.6% | · | · | · | |
| EPS YoY (EPS YB) | -25.9% | · | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | -25.7% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | ADMA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.9 | · | 0.1 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 1.2 | · | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 4.9 | · | 7.2 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$797.1K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-7.5%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $0.16 | $0.18 | -9.1% |
| 31 Mart 2026 | May 13, 2026 | $0.19 | $0.20 | -6.9% |
| 31 Aralık 2025 | $0.20 | $0.19 | 6.0% | |
| 30 Eylül 2025 | $0.15 | $0.15 | -2.0% | |
| 30 Haziran 2025 | $0.14 | $0.14 | -2.0% | |
| 31 Mart 2025 | $0.11 | $0.16 | -31.2% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $510M | $426M | $258M | $154M | $81M | $42M | $29M | $17M | $23M | $11M | $7M | $6M | |
| Cost of Revenue | $217M | $207M | $169M | $119M | $80M | $61M | $40M | $42M | $29M | $2M | $4M | $4M | |
| Gross Profit | $293M | $220M | $89M | $35M | $1M | $-19M | · | $-25M | $-6M | $4M | $3M | $2M | |
| R&D Expense | $5M | $2M | $3M | $4M | $4M | $6M | $2M | $4M | $6M | $8M | $7M | $10M | |
| SG&A Expense | $92M | $74M | $59M | $52M | $43M | $35M | $26M | $23M | $19M | $8M | $7M | $5M | |
| Operating Expenses | $101M | $81M | $67M | $75M | $60M | $46M | $71M | $77M | $62M | $28M | $23M | $22M | |
| Operating Income | $191M | $139M | $22M | $-39M | $-58M | $-65M | $-41M | $-60M | $-39M | $-17M | $-16M | $-16M | |
| Interest Expense | · | · | $25M | $19M | $13M | $12M | $9M | $6M | $3M | $2M | $2M | $1M | |
| Interest Income | $2M | $2M | $2M | $45.0K | $35.0K | $288.1K | $800.8K | · | · | · | · | · | |
| Other Non-op | $-212.0K | $-193.0K | $-287.0K | $-635.0K | $-252.0K | $-128.5K | $-227.3K | $-127.1K | $-10.1K | $4.5K | $-2M | $-1M | |
| Pretax Income | $183M | $126M | $-28M | $-66M | · | · | · | · | · | $-20M | $-18M | $-17M | |
| Income Tax | $36M | $-72M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-551.7K | |
| Net Income | $147M | $198M | $-28M | $-66M | $-72M | $-76M | $-48M | $-66M | $-44M | $-20M | $-18M | $-17M | |
| EPS (Basic) | $0.62 | $0.85 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · | |
| EPS (Diluted) | $0.60 | $0.81 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · | |
| Shares (Basic) | 238,299,024 | 233,084,236 | 223,977,315 | 197,874,895 | 139,578,538 | 86,145,052 | · | · | · | · | · | · | |
| Shares (Diluted) | 244,904,640 | 243,342,466 | 223,977,315 | 197,874,895 | 139,578,538 | 86,145,052 | · | · | · | · | · | · | |
| EBITDA | $199M | $147M | $29M | $-33M | $-54M | $-62M | $-39M | $-58M | $-38M | $-17M | $-15M | $-16M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $103M | $51M | $87M | $51M | $56M | $27M | $27M | $43M | $10M | $10M | $17M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $0 | $5M | $6M | $5M | |
| Receivables | $158M | $50M | $27M | $16M | $29M | $13M | $3M | $1M | $4M | $1M | $924.5K | $384.0K | |
| Inventory | $206M | $170M | $173M | $163M | $125M | $82M | $53M | $19M | $13M | $5M | $3M | $2M | |
| Prepaid Expense | $7M | $8M | $5M | $5M | $4M | $3M | $3M | $2M | $1M | $313.9K | $111.0K | $143.6K | |
| Current Assets | $467M | $331M | $257M | $270M | $209M | $154M | $86M | $45M | $62M | $22M | $21M | $24M | |
| PP&E (Net) | $65M | $55M | $54M | $58M | $51M | $42M | $32M | $30M | $30M | $2M | $2M | $3M | |
| PP&E (Gross) | $103M | $88M | $81M | $78M | $64M | $50M | $37M | $34M | $32M | $4M | $4M | $4M | |
| Accum. Depreciation | $38M | $34M | $27M | $19M | $13M | $9M | $6M | $3M | $1M | $2M | $2M | $1M | |
| Goodwill | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $0 | · | · | |
| Intangibles | $632.0K | $460.0K | $499.0K | $1M | $2M | $2M | $3M | $4M | $5M | $0 | · | · | |
| Total Assets | $624M | $489M | $329M | $348M | $276M | $208M | $127M | $89M | $108M | $24M | $24M | $27M | |
| Accounts Payable | $23M | $20M | $16M | $13M | $12M | $11M | $9M | $6M | $6M | $3M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | · | $8M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | $0 | $6M | $0 | · | |
| Current Liabilities | $70M | $56M | $50M | $39M | $30M | $20M | $14M | $10M | $9M | $11M | $4M | $4M | |
| Capital Leases | $7M | $9M | $10M | $11M | $7M | $4M | $1M | $119.1K | $0 | $19.7K | $36.3K | $51.4K | |
| Other Non-current Liabilities | $0 | $360.0K | $419.0K | $350.0K | $397.4K | $54.9K | $106.6K | $260.7K | $106.0K | $117.8K | $1M | $132.5K | |
| Total Liabilities | $147M | $140M | $194M | $196M | $135M | $119M | $101M | $69M | $68M | $28M | $23M | $21M | |
| Long-term Debt | $72M | $72M | · | · | · | · | $0 | $3M | $3M | $2M | · | · | |
| Total Debt | $72M | · | · | · | · | · | · | $0 | $0 | $6M | · | · | |
| Common Stock | $24.0K | $24.0K | $23.0K | $22.0K | $19.6K | $10.5K | $5.9K | $4.6K | $3.7K | $1.3K | $1.1K | $929 | |
| Paid-in Capital | $671M | $658M | $641M | $630M | $553M | $429M | $291M | $236M | $191M | $102M | $88M | $75M | |
| Retained Earnings | $-162M | $-309M | $-506M | $-478M | $-412M | $-340M | $-265M | $-216M | $-151M | $-107M | $-87M | $-69M | |
| Treasury Stock | $32M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $477M | $349M | $135M | $152M | $141M | $88M | $26M | $20M | $40M | $-4M | $821.0K | $6M | |
| Liabilities + Equity | $624M | $489M | $329M | $348M | $276M | $208M | $127M | $89M | $108M | $24M | $24M | $27M | |
| Shares Outstanding | 237,874,496 | 236,620,545 | 226,063,032 | 221,816,930 | 195,813,817 | 104,902,888 | 59,318,355 | 46,353,068 | 36,725,499 | 12,886,741 | 10,713,087 | 9,291,823 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $8M | $6M | $5M | $3M | $2M | $3M | $2M | $400.0K | $469.8K | $247.9K | |
| Stock-based Comp | $20M | $14M | $6M | $5M | $3M | $3M | $3M | $2M | $2M | $1M | $2M | $1M | |
| Deferred Tax | $11M | $-84M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $144.0K | $388.0K | $724.0K | $715.0K | $715.0K | $715.4K | $844.9K | $844.9K | $1M | $0 | · | · | |
| Other Non-cash | $-136M | $-16M | $23M | $-5M | $-49M | $-32M | $-33M | $-2M | $3M | $-473.5K | $370.7K | $611.9K | |
| Operating Cash Flow | $50M | $119M | $9M | $-60M | $-112M | $-102M | $-76M | $-63M | $-37M | $-18M | $-15M | $-15M | |
| CapEx | $23M | $8M | $5M | $14M | $14M | $13M | $4M | $2M | $3M | $73.4K | $26.1K | $2M | |
| Investing Cash Flow | $-22M | $-9M | $-5M | $-14M | $-14M | $-13M | $-4M | $-2M | $15M | $904.6K | $-2M | $-4M | |
| Debt Issued | · | · | · | · | · | $28M | $72M | $0 | $30M | $4M | · | · | |
| Net Debt Issued | · | · | · | · | · | $14M | $72M | $0 | $30M | · | · | · | |
| Stock Issued | · | $0 | $0 | $65M | $121M | $131M | $48M | $43M | $39M | $13M | $10M | $0 | |
| Stock Repurchased | $32M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-32M | $0 | $0 | $65M | $121M | $131M | $48M | $43M | $39M | $14M | $10M | $0 | |
| Financing Cash Flow | $-44M | $-58M | $-39M | $109M | $121M | $144M | $80M | $43M | $61M | $17M | $10M | $10M | |
| Net Change in Cash | $-16M | $52M | $-35M | $35M | $-5M | $29M | $-2.7K | $-22M | $39M | $-526.1K | $-7M | $-9M | |
| Taxes Paid | $20M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $28M | $110M | $4M | $-73M | $-126M | $-115M | $-80M | $-65M | $-40M | $-18M | $-15M | $-17M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-21M | $-17M | $-18M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.4% | 51.5% | 34.4% | 22.9% | 1.5% | · | · | -148.4% | -28.1% | 40.3% | 39.9% | 36.7% | |
| Operating Margin | 37.5% | 32.6% | 8.4% | -25.6% | -72.1% | -153.8% | -141.1% | -354.9% | -172.7% | -162.6% | -216.1% | -270.8% | |
| Net Margin | 28.8% | 46.4% | -10.9% | -42.8% | -88.5% | -179.4% | -164.5% | -387.1% | -192.3% | -183.1% | -250.4% | -284.2% | |
| Pretax Margin | 35.8% | 29.5% | · | · | · | · | · | · | · | -183.1% | -250.4% | -293.6% | |
| EBITDA Margin | 39.1% | 34.4% | 11.3% | -21.4% | -66.2% | -146.2% | -133.0% | -339.6% | -166.1% | -158.1% | -209.6% | -266.6% | |
| ROA | 26.4% | 45.0% | -8.3% | -20.3% | -27.8% | -38.1% | -47.0% | -67.3% | -66.5% | -82.3% | -70.8% | -56.8% | |
| ROE | 33.6% | 68.1% | -19.7% | -52.2% | -58.7% | -94.9% | -155.0% | -230.8% | -243.9% | 1073.4% | -526.2% | -153.5% | |
| ROIC | 28.0% | 62.6% | · | · | · | · | · | · | · | -1047.9% | -1889.7% | -258.1% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 6.0 | 5.2 | 6.9 | 6.9 | 7.7 | 6.1 | 4.6 | 6.7 | 1.9 | 5.0 | 5.7 | |
| Quick Ratio | 3.5 | 2.8 | 1.6 | 2.6 | 2.6 | 3.5 | 2.2 | 2.5 | 5.0 | 1.5 | 4.2 | 5.3 | |
| Debt / Equity | 0.2 | · | · | · | · | · | · | 0.0 | 0.0 | -1.4 | · | · | |
| LT Debt / Equity | 0.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 0.9 | -2.0 | -4.5 | -5.4 | -4.6 | -10.9 | -12.0 | -7.7 | -8.4 | -12.5 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.0 | 0.8 | 0.5 | 0.3 | 0.2 | 0.3 | 0.2 | 0.3 | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | 1.2 | 1.2 | 1.0 | 0.8 | 0.8 | 0.9 | 1.1 | 2.7 | 0.3 | 1.5 | 1.7 | 2.8 | |
| Receivables Turnover | 4.9 | 11.0 | 12.0 | 7.0 | 3.9 | 5.1 | 12.1 | 6.4 | 9.3 | 11.0 | 11.0 | 13.6 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.01 | $1.48 | $0.60 | $0.69 | $0.72 | $0.84 | $0.44 | $0.43 | $1.10 | $-0.35 | $0.08 | $0.65 | |
| Revenue / Share | $2.08 | $1.75 | $1.15 | $0.78 | $0.58 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.21 | $0.49 | $0.04 | $-0.30 | $-0.81 | · | · | · | · | · | · | · | |
| Cash / Share | $0.37 | $0.44 | $0.23 | $0.39 | $0.26 | $0.53 | $0.45 | $0.49 | $1.17 | $0.77 | $0.97 | $1.85 | |
| EPS (TTM) | $0.60 | $0.81 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.6% | 65.1% | 67.6% | 90.4% | 91.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 49.0% | 74.0% | 82.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 64.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -25.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -25.7% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $510M | $426M | $258M | $154M | $81M | $42M | $29M | $17M | $23M | $11M | $7M | $6M | |
| Net Income TTM | $147M | $198M | $-28M | $-66M | $-72M | $-76M | $-48M | $-66M | $-44M | $-20M | $-18M | $-17M | |
| Market Cap | $4.34B | $4.06B | $1.02B | $861M | $276M | $205M | $237M | $111M | $118M | $66M | $86M | $104M | |
| Enterprise Value | $4.32B | · | · | · | · | · | · | $88M | $75M | $57M | · | · | |
| P/E | 30.4 | 21.2 | -34.8 | -11.8 | -2.8 | -2.2 | · | · | · | · | · | · | |
| P/S | 8.5 | 9.5 | 4.0 | 5.6 | 3.4 | 4.8 | 8.1 | 6.5 | 5.2 | 6.2 | 12.0 | 17.5 | |
| P/B | 9.1 | 11.6 | 7.6 | 5.7 | 2.0 | 2.3 | 9.1 | 5.6 | 2.9 | -14.8 | 105.3 | 17.3 | |
| P / Tangible Book | 9.2 | 11.8 | 7.8 | 5.8 | 2.0 | 2.5 | · | · | · | · | · | · | |
| P / Cash Flow | 86.1 | 34.2 | 116.1 | -14.5 | -2.5 | -2.0 | -3.1 | -1.8 | -3.2 | -3.6 | -5.6 | -7.1 | |
| P / FCF | 156.0 | 36.7 | 253.6 | -11.7 | -2.2 | -1.8 | -3.0 | -1.7 | -3.0 | -3.6 | -5.6 | -6.1 | |
| EV / EBITDA | 21.7 | · | · | · | · | · | · | -1.5 | -2.0 | -3.4 | · | · | |
| EV / FCF | 155.4 | · | · | · | · | · | · | -1.4 | -1.9 | -3.1 | · | · | |
| EV / Revenue | 8.5 | · | · | · | · | · | · | 5.2 | 3.3 | 5.3 | · | · | |
| Earnings Yield | 3.3% | 4.7% | -2.9% | -8.5% | -36.2% | -45.1% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124M | $114M | $139M | $134M | $122M | $115M | $118M | $120M | $107M | $82M | $74M | $67M | $60M | $57M | $50M | $41M | |
| Cost of Revenue | $38M | $34M | $50M | $59M | $55M | $54M | $54M | $60M | $50M | $43M | $43M | $43M | $43M | $40M | $36M | $31M | |
| Gross Profit | $86M | $81M | $89M | $76M | $67M | $61M | $63M | $60M | $57M | $39M | $31M | $25M | $17M | $17M | $14M | $10M | |
| R&D Expense | $6M | $3M | $1M | $2M | $1M | $826.0K | $391.0K | $412.0K | $560.0K | $450.0K | $446.0K | $596.0K | $1M | $855.0K | $1M | $1M | |
| SG&A Expense | $27M | $27M | $24M | $22M | $22M | $24M | $23M | $19M | $17M | $16M | $16M | $15M | $14M | $15M | $14M | $13M | |
| Operating Expenses | $34M | $22M | $26M | $25M | $24M | $26M | $25M | $20M | $18M | $17M | $17M | $16M | $17M | $17M | $20M | $19M | |
| Operating Income | $52M | $58M | $63M | $51M | $43M | $35M | $38M | $40M | $39M | $22M | $14M | $9M | $-473.0K | $-813.0K | $-6M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $6M | $6M | $6M | · | $6M | |
| Interest Income | · | · | $487.0K | $376.0K | $400.0K | $608.0K | $598.0K | $666.0K | $449.0K | $384.0K | $614.0K | $423.0K | $414.0K | $166.0K | $2.4K | $7.2K | |
| Other Non-op | $-22.0K | $-140.0K | $-19.0K | $-21.0K | $-108.0K | $-64.0K | $-86.0K | $-56.0K | $-16.0K | $-35.0K | $-102.0K | $-145.0K | $-13.0K | $-27.0K | $-439.1K | $-9.6K | |
| Pretax Income | $50M | $57M | $62M | $48M | $40M | $33M | $35M | $37M | $36M | $18M | $-18M | $3M | $-6M | $-7M | · | · | |
| Income Tax | $12M | $12M | $12M | $11M | $6M | $7M | $-77M | $840.0K | $4M | $595.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $38M | $45M | $49M | $36M | $34M | $27M | $112M | $36M | $32M | $18M | $-18M | $3M | $-6M | $-7M | $-12M | $-15M | |
| EPS (Basic) | $0.17 | $0.19 | $0.22 | $0.15 | $0.14 | $0.11 | $0.48 | $0.15 | $0.14 | $0.08 | $-0.08 | $0.01 | $-0.03 | $-0.03 | $-0.05 | $-0.08 | |
| EPS (Diluted) | $0.16 | $0.19 | $0.20 | $0.15 | $0.14 | $0.11 | $0.45 | $0.15 | $0.13 | $0.08 | $-0.08 | $0.01 | $-0.03 | $-0.03 | $-0.05 | $-0.08 | |
| Shares (Basic) | 228,232,503 | 236,072,751 | · | 238,602,978 | 241,490,715 | 237,775,476 | · | 234,571,376 | 232,417,645 | 228,874,847 | · | 225,276,980 | 222,683,393 | 221,921,750 | · | 196,383,935 | |
| Shares (Diluted) | 230,337,048 | 239,955,762 | · | 244,664,263 | 248,608,460 | 244,676,350 | · | 244,804,065 | 242,167,072 | 236,414,374 | · | 233,761,262 | 222,683,393 | 221,921,750 | · | 196,383,935 | |
| EBITDA | $54M | $60M | · | $53M | $45M | $37M | · | $42M | $41M | $24M | · | $11M | $1M | $1M | · | $-8M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $136M | $138M | $88M | $61M | $90M | $72M | $103M | $87M | $88M | $45M | · | $74M | $63M | $69M | · | $35M | |
| Receivables | $138M | $136M | $158M | $138M | $110M | $99M | $50M | $50M | $30M | $50M | · | $31M | $37M | $27M | · | $21M | |
| Inventory | $239M | $222M | $206M | $197M | $191M | $172M | $170M | $172M | $180M | $178M | · | $163M | $162M | $164M | · | $163M | |
| Prepaid Expense | $15M | $15M | $7M | $7M | $8M | $9M | $8M | $10M | $6M | $4M | · | $5M | $5M | $4M | · | $5M | |
| Current Assets | $528M | $511M | $467M | $403M | $400M | $352M | $331M | $318M | $304M | $276M | · | $274M | $266M | $264M | · | $224M | |
| PP&E (Net) | $67M | $65M | $65M | $70M | $58M | $58M | $55M | $54M | $54M | $55M | · | $55M | $56M | $57M | · | $57M | |
| PP&E (Gross) | $108M | $105M | $103M | · | $95M | $93M | $88M | $86M | $85M | $84M | · | $80M | $80M | $79M | · | $75M | |
| Accum. Depreciation | $42M | $40M | $38M | · | $38M | $35M | $34M | $32M | $31M | $29M | · | $25M | $23M | $21M | · | $18M | |
| Goodwill | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Intangibles | $575.0K | $630.0K | $632.0K | $491.0K | $527.0K | $452.0K | $460.0K | $485.0K | $479.0K | $321.0K | · | $476.9K | $655.7K | $834.6K | · | $1M | |
| Total Assets | $684M | $665M | $624M | $569M | $558M | $511M | $489M | $391M | $376M | $351M | $329M | $349M | $343M | $341M | $348M | $301M | |
| Accounts Payable | $32M | $21M | $23M | $24M | $30M | $21M | $20M | $16M | $14M | $17M | · | $11M | $12M | $13M | · | $25M | |
| Current Liabilities | $76M | $74M | $70M | $56M | $75M | $53M | $56M | $45M | $44M | $53M | · | $42M | $42M | $37M | · | $44M | |
| Capital Leases | $6M | $6M | $7M | $9M | $9M | $8M | $9M | $9M | $9M | $9M | · | $10M | $10M | $10M | · | $11M | |
| Other Non-current Liabilities | · | · | $0 | $90.0K | $2.0K | $2.0K | $360.0K | $375.0K | $390.0K | $405.0K | · | $434.6K | $449.5K | $338.7K | · | $362.2K | |
| Total Liabilities | $276M | $275M | $147M | $138M | $160M | $137M | $140M | $159M | $188M | $197M | · | $198M | $196M | $195M | · | $200M | |
| Long-term Debt | $197M | $197M | $72M | $72M | · | · | $72M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $197M | $197M | · | $72M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $23.0K | $23.0K | · | $22.6K | $22.5K | $22.2K | · | $19.7K | |
| Paid-in Capital | $675M | $650M | $671M | $665M | $661M | $655M | $658M | $652M | $645M | $642M | · | $640M | $638M | $630M | · | $566M | |
| Retained Earnings | $-79M | $-116M | $-162M | $-211M | $-247M | $-282M | $-309M | $-420M | $-456M | $-488M | · | $-489M | $-491M | $-485M | · | $-466M | |
| Treasury Stock | $188M | $143M | $32M | $23M | $15M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $408M | $390M | $477M | $431M | $398M | $373M | $349M | $232M | $188M | $154M | $135M | $151M | $147M | $146M | $152M | $100M | |
| Liabilities + Equity | $684M | $665M | $624M | $569M | $558M | $511M | $489M | $391M | $376M | $351M | · | $349M | $343M | $341M | · | $301M | |
| Shares Outstanding | 225,355,228 | 232,288,977 | 237,874,496 | 238,332,393 | 238,567,308 | 238,532,252 | 236,620,545 | 236,378,607 | 233,026,736 | 231,769,765 | · | 225,958,084 | 224,526,748 | 222,262,588 | · | 196,776,871 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Deferred Tax | $3.0K | $3M | $1M | $5M | $2M | $3M | $-84M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Amort. of Intangibles | $55.0K | $55.0K | $49.0K | $38.0K | $32.0K | $25.0K | $25.0K | $28.0K | $142.0K | $193.0K | $187.0K | $179.0K | $179.0K | $179.0K | $178.5K | $178.8K | |
| Other Non-cash | · | $2M | · | · | · | $-57M | · | · | · | $-24M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $30M | $58M | $36M | $13M | $21M | $-20M | $50M | $25M | $46M | $-2M | $18M | $12M | $-6M | $-15M | $-7M | $-13M | |
| CapEx | $2M | $3M | $1M | $14M | $2M | $5M | $3M | $1M | $2M | $2M | $1M | $756.8K | $872.4K | $2M | $4M | $3M | |
| Investing Cash Flow | $-2M | $2M | $-276.0K | $-14M | $-3M | $-5M | $-3M | $-1M | $-2M | $-2M | $-1M | $-756.8K | $-872.4K | $-2M | $-4M | $-3M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $65M | $0 | |
| Stock Repurchased | $25M | $130M | $9M | $23M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-130M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-29M | $-10M | $-9M | $-28M | $48.0K | $-7M | $-31M | $-25M | $-362.0K | $-1M | $-39M | $416.4K | $240.5K | $-650.0K | $63M | $-843.8K | |
| Net Change in Cash | $-2M | $51M | $26M | $-29M | $19M | $-32M | $16M | $-2M | $43M | $-6M | $-23M | $12M | $-7M | $-17M | $52M | $-18M | |
| Free Cash Flow | · | $56M | · | · | · | $-24M | · | · | · | $-5M | · | · | · | $-17M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.4% | 70.5% | · | 56.3% | 55.1% | 53.2% | · | 49.8% | 53.6% | 47.8% | · | 36.6% | 27.8% | 29.0% | · | 23.5% | |
| Operating Margin | 42.2% | 50.9% | · | 38.0% | 35.1% | 30.4% | · | 33.1% | 36.6% | 26.7% | · | 12.9% | -0.79% | -1.4% | · | -22.7% | |
| Net Margin | 30.4% | 39.6% | · | 27.1% | 28.1% | 23.4% | · | 30.0% | 29.9% | 21.8% | · | 3.8% | -10.6% | -11.9% | · | -36.3% | |
| Pretax Margin | 40.4% | 49.9% | · | 35.4% | 32.9% | 29.1% | · | 30.7% | 33.5% | 22.5% | · | · | · | · | · | · | |
| EBITDA Margin | 43.5% | 52.5% | · | 39.5% | 36.7% | 32.0% | · | 34.7% | 38.3% | 29.0% | · | 15.7% | 2.4% | 1.9% | · | -18.5% | |
| ROA | 6.1% | 7.7% | · | 7.6% | 7.3% | 6.2% | · | 9.7% | 8.9% | 5.1% | · | 0.79% | -2.0% | -2.1% | · | -5.5% | |
| ROE | 9.4% | 11.9% | · | 11.0% | 11.7% | 10.2% | · | 18.7% | 19.1% | 11.9% | · | 2.0% | -4.9% | -5.0% | · | -14.7% | |
| ROIC | 6.5% | 7.9% | · | 7.8% | 9.2% | 7.5% | · | 16.7% | 18.6% | 13.7% | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 7.0 | · | 7.1 | 5.3 | 6.6 | · | 7.1 | 6.9 | 5.2 | · | 6.5 | 6.3 | 7.2 | · | 5.0 | |
| Quick Ratio | 3.6 | 3.7 | · | 3.5 | 2.7 | 3.2 | · | 3.0 | 2.7 | 1.8 | · | 2.5 | 2.4 | 2.6 | · | 1.3 | |
| Debt / Equity | 0.5 | 0.5 | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.8 | · | 1.4 | -0.1 | -0.1 | · | -1.7 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.4 | 1.7 | 1.5 | · | 2.9 | 3.2 | 2.2 | · | 2.6 | 2.2 | 2.2 | · | 2.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.81 | $1.68 | · | $1.81 | $1.67 | $1.57 | · | $0.98 | $0.81 | $0.66 | · | $0.67 | $0.65 | $0.66 | · | $0.51 | |
| Revenue / Share | $0.54 | $0.48 | · | $0.55 | $0.49 | $0.47 | · | $0.49 | $0.44 | $0.35 | · | $0.29 | $0.27 | $0.26 | · | $0.21 | |
| Cash Flow / Share | · | $0.24 | · | · | · | $-0.08 | · | · | · | $-0.01 | · | · | · | $-0.07 | · | · | |
| Cash / Share | $0.60 | $0.59 | · | $0.26 | $0.38 | $0.30 | · | $0.37 | $0.38 | $0.20 | · | $0.33 | $0.28 | $0.31 | · | $0.18 | |
| EPS (TTM) | $0.70 | $0.68 | · | $0.85 | $0.85 | $0.84 | · | $0.28 | $0.14 | $-0.02 | · | $-0.10 | $-0.19 | $-0.23 | · | $-0.35 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $512M | $510M | · | $489M | $474M | $459M | · | $383M | $330M | $283M | · | $234M | $208M | $182M | · | $130M | |
| Net Income TTM | $169M | $165M | · | $209M | $209M | $207M | · | $68M | $35M | $-4M | · | $-23M | $-40M | $-48M | · | $-70M | |
| Market Cap | $1.89B | $2.09B | · | $3.49B | $4.34B | $4.73B | · | $4.73B | $2.61B | $1.53B | · | $809M | $829M | $736M | · | $478M | |
| Enterprise Value | $1.95B | $2.15B | · | $3.50B | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 12.0 | 13.2 | · | 17.2 | 21.4 | 23.6 | · | 71.4 | 79.9 | -330.0 | · | -35.8 | -19.4 | -14.4 | · | -6.9 | |
| P/S | 3.7 | 4.1 | · | 7.2 | 9.2 | 10.3 | · | 12.3 | 7.9 | 5.4 | · | 3.5 | 4.0 | 4.0 | · | 3.7 | |
| P/B | 4.6 | 5.4 | · | 8.1 | 10.9 | 12.7 | · | 20.4 | 13.8 | 10.0 | · | 5.3 | 5.6 | 5.1 | · | 4.8 | |
| P / Tangible Book | 4.7 | 5.4 | · | 8.2 | 11.0 | 12.8 | · | 20.7 | 14.1 | 10.2 | · | 5.5 | 5.8 | 5.2 | · | 5.0 | |
| P / Cash Flow | · | 35.9 | · | · | · | -240.5 | · | · | · | -689.7 | · | · | · | -50.0 | · | · | |
| EV / Revenue | 3.8 | 4.2 | · | 7.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 8.4% | 7.5% | · | 5.8% | 4.7% | 4.2% | · | 1.4% | 1.2% | -0.30% | · | -2.8% | -5.1% | -7.0% | · | -14.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Gelir | $510M | · | · | $426M | · |
| Brüt Kâr Marjı % | 57.4% | · | · | 51.5% | · |
| Faaliyet Kâr Marjı % | 37.5% | · | · | 32.6% | · |
| Net Gelir | $147M | · | · | $198M | · |
| Seyreltilmiş Hisse Başı Kâr | $0.60 | · | · | $0.81 | · |
| Metrik | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.2 | · | · | · | · |
| Cari Oran | 6.7 | · | · | 6.0 | · |
| Cari Oran | 3.5 | · | · | 2.8 | · |
| Metrik | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $28M | · | · | $110M | · |
Kurumsal Sahipler (13F) 361 dosya · $2.1B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
361
Tutulan Değer
$2.1B
Yeni pozisyonlar
53
Çıkan pozisyonlar
82
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 53 (-23 önceki Ç'ye göre) | 82 (+21 önceki Ç'ye göre) | 90 (-48 önceki Ç'ye göre) | 151 (+41 önceki Ç'ye göre) | -9.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $380.389.162 | 20.854.669 | 18,30% | Hisse senetleri |
| BlackRock, Inc. | $321.037.075 | 38.355.684 | 15,44% | Hisse senetleri |
| STATE STREET CORP | $143.261.104 | 17.116.022 | 6,89% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.568.881 | 10.103.809 | 4,07% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $84.440.661 | 10.088.490 | 4,06% | Hisse senetleri |
| Rubric Capital Management LP | $78.170.895 | 9.339.414 | 3,76% | Hisse senetleri |
| Capital Research Global Investors | $73.290.850 | 8.756.374 | 3,53% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $65.272.197 | 7.798.351 | 3,14% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $50.731.358 | 6.059.984 | 2,44% | Hisse senetleri |
| Caligan Partners LP | $47.918.309 | 5.725.007 | 2,31% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $44.148.376 | 5.274.597 | 2,12% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $30.183.960 | 3.606.208 | 1,45% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $29.408.690 | 3.513.583 | 1,41% | Hisse senetleri |
| B Group, Inc. | $27.307.477 | 3.262.542 | 1,31% | Hisse senetleri |
| Nuveen, LLC | $27.289.121 | 3.260.349 | 1,31% | Hisse senetleri |
| NORTHERN TRUST CORP | $20.221.678 | 2.415.971 | 0,97% | Hisse senetleri |
| Nantahala Capital Management, LLC | $19.753.141 | 2.359.993 | 0,95% | Hisse senetleri |
| MORGAN STANLEY | $18.961.760 | 2.265.443 | 0,91% | Hisse senetleri |
| Ranger Investment Management, L.P. | $17.706.040 | 2.115.417 | 0,85% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17.515.012 | 2.092.594 | 0,84% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $16.906.454 | 2.019.887 | 0,81% | Hisse senetleri |
| KENNEDY CAPITAL MANAGEMENT LLC | $14.690.622 | 1.755.152 | 0,71% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $13.849.111 | 1.654.613 | 0,67% | Hisse senetleri |
| Fundsmith LLP | $13.806.256 | 1.649.493 | 0,66% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $13.790.805 | 1.647.647 | 0,66% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $12.769.114 | 1.525.581 | 0,61% | Hisse senetleri |
| Life Cycle Investment Partners Ltd | $12.747.351 | 1.522.981 | 0,61% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $12.172.449 | 1.454.295 | 0,59% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $11.548.114 | 1.379.703 | 0,56% | Hisse senetleri |
| CITADEL ADVISORS LLC | $11.467.494 | 1.370.071 | 0,55% | Hisse senetleri |
| Clearline Capital LP | $11.171.648 | 1.334.725 | 0,54% | Hisse senetleri |
| Qube Research & Technologies Ltd | $11.019.674 | 1.316.568 | 0,53% | Hisse senetleri |
| Bank of New York Mellon Corp | $10.468.003 | 1.250.658 | 0,50% | Hisse senetleri |
| National Philanthropic Trust | $10.006.302 | 1.195.496 | 0,48% | Hisse senetleri |
| BOOTHBAY FUND MANAGEMENT, LLC | $9.848.828 | 1.176.682 | 0,47% | Hisse senetleri |
| UBS Group AG | $9.818.286 | 1.173.033 | 0,47% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $9.660.888 | 1.154.228 | 0,46% | Hisse senetleri |
| FEDERATED HERMES, INC. | $8.494.019 | 1.014.817 | 0,41% | Hisse senetleri |
| Caption Management, LLC | $8.370.000 | 1.000.000 | 0,40% | Satım opsiyonu |
| DEUTSCHE BANK AG\ | $8.174.242 | 976.612 | 0,39% | Hisse senetleri |
| Stonepine Capital Management, LLC | $7.950.000 | 650.000 | 0,38% | Alım opsiyonu |
| ROYAL BANK OF CANADA | $7.368.000 | 880.330 | 0,35% | Hisse senetleri |
| Public Sector Pension Investment Board | $6.664.370 | 796.221 | 0,32% | Hisse senetleri |
| ALGERT GLOBAL LLC | $6.505.072 | 777.189 | 0,31% | Hisse senetleri |
| Stonepine Capital Management, LLC | $6.193.800 | 740.000 | 0,30% | Hisse senetleri |
| Russell Investments Group, Ltd. | $6.092.357 | 727.880 | 0,29% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.749.537 | 686.922 | 0,28% | Hisse senetleri |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $5.582.790 | 667.000 | 0,27% | Hisse senetleri |
| JANE STREET GROUP, LLC | $5.541.626 | 662.082 | 0,27% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $5.461.676 | 652.530 | 0,26% | Hisse senetleri |
Aktivistler ve %5+ sahipler 9 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Caligan Partners LP, David Johnson ×2 başvurular | 09 Aralık 2022 | · | İlk başvuru | Pasif yatırım | SEC |
| The Biotest Divestiture Trust, Eric Rosenbach ×2 başvurular | 07 Haziran 2019 | · | İlk başvuru | · | SEC |
| Biotest AG ×3 başvurular | 03 Ağustos 2018 | · | İlk başvuru | · | SEC |
| Biotest Pharmaceuticals Corporation | 21 Mayıs 2018 | · | İlk başvuru | · | SEC |
| OR ×8 başvurular | 16 Kasım 2017 | · | İlk başvuru | · | SEC |
| Biomark Capital Fund IV LP (the “Fund”), Biomark Capital Fund IV GP LLC (the “General Partner”), David S. Wetherell (“Wetherell”) | 30 Ocak 2017 | · | İlk başvuru | Pasif yatırım | SEC |
| Burrill Capital Fund IV, L.P. (the “Fund”), Burrill & Company (BCF IV GP), LLC (the “General Partner”), G. Steven Burrill (“Burrill”), Bryant Fong (“Fong”), Victor Hebert (“Hebert”), Douglas Lind (“Lind”), David Wetherell (“Wetherell”), Joshua Zelig (“Zelig”) ×2 başvurular | 28 Ekim 2013 | · | İlk başvuru | Pasif yatırım | SEC |
| Açıklanmayan raporlama kişisi | 15 Eylül 2006 | · | İlk başvuru | · | SEC |
| Açıklanmayan raporlama kişisi | 08 Eylül 2006 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 20 içeriden öğrenenler · 8 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Adam S Grossman | President and CEO | 16 Mart 2026 M | 2.112.777 | 0 | 10 | $-1.743.630 |
| Terry Kohler | CFO and Treasurer | 16 Temmuz 2026 A | 143.149 | 0 | 0 | $0 |
| Brad L. Tade | CFO and Treasurer | 19 Şubat 2026 F | 232.940 | 0 | 0 | $0 |
| Brian Lenz | EVP, CFO | 07 Mart 2024 F | 703.002 | 0 | 0 | $0 |
| Kirk M Warshaw | CFO, Secretary | 13 Şubat 2012 D | 5.208 | 0 | 0 | $0 |
| Arnold P Kling | President | 13 Şubat 2012 D | 8.485 | 0 | 0 | $0 |
| Kaitlin M. Kestenberg-Messina | COO and SVP, Compliance | 24 Temmuz 2026 F | 443.061 | 0 | 1 | $-157.800 |
| James Mond | EVP, CSO and CMO | 25 Şubat 2021 A | 137.535 | 0 | 0 | $0 |
| Jerrold B Grossman | Yönetim kurulu üyesi | 27 Mayıs 2026 P | 520.284 | 3 | 0 | $250.874 |
| Lawrence P. Guiheen | Yönetim kurulu üyesi | 13 Mart 2026 M | 30.000 | 0 | 0 | $0 |
| Steve Elms | Yönetim kurulu üyesi | 06 Mart 2026 P | 2.045.730 | 2 | 0 | $217.420 |
| Eduardo Rene Salas | Yönetim kurulu üyesi | 09 Şubat 2026 A | 21.579 | 0 | 0 | $0 |
| Young Kwon | Yönetim kurulu üyesi | 09 Şubat 2026 A | 263.020 | 0 | 0 | $0 |
| Alison Cecily Finger | Yönetim kurulu üyesi | 09 Şubat 2026 A | 45.619 | 0 | 0 | $0 |
| Bryant Fong | Yönetim kurulu üyesi | 26 Şubat 2024 A | 83.941 | 0 | 0 | $0 |
| Martha J Demski | Yönetim kurulu üyesi | 06 Mart 2023 A | 56.601 | 0 | 0 | $0 |
| Eric I Richman | Yönetim kurulu üyesi | 28 Şubat 2020 A | 44.030 | 0 | 0 | $0 |
| GOLDSTEIN DOV A MD | Yönetim kurulu üyesi | 28 Şubat 2020 A | 7.500 | 0 | 0 | $0 |
| Biotest Divestiture Trust | 10% sahip | 06 Haziran 2019 S | 4.295.580 | 0 | 0 | $0 |
| R & R INVESTMENTS VI LLC | 10% sahip | 13 Şubat 2012 D | 39.340 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 46 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,42% | 165.305 NS | 31 Temmuz 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,21% | 215.300 SH | 01 Ekim 2026 | Günlük |
| LABU · Direxion Shares ETF Trust | 0,45% | 264.044 NS | 31 Temmuz 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,34% | 12.285 NS | 31 Temmuz 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 0,31% | 37.244 SH | 01 Ekim 2026 | Günlük |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,21% | 275.878 SH | 19 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,16% | 1.726.703 SH | 11 Eylül 2026 | Günlük |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,15% | 34.756 SH | 01 Ekim 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,15% | 15.852 SH | 01 Ekim 2026 | Günlük |
| IWO · iShares Trust | 0,14% | 2.176.078 SH | 11 Eylül 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,13% | 3.607 NS | 31 Temmuz 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,11% | 247.366 SH | 19 Ağustos 2026 | Günlük |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,10% | 807.920 SH | 19 Ağustos 2026 | Günlük |
| BKSE · BNY Mellon ETF Trust | 0,08% | 8.685 NS | 31 Temmuz 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 61.860 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 5.882.053 SH | 11 Eylül 2026 | Günlük |
| ISCG · iShares Trust | 0,07% | 72.134 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 1.327.333 SH | 19 Ağustos 2026 | Günlük |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 32.883 NS | 31 Temmuz 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,04% | 617 NS | 31 Temmuz 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,04% | 68.652 SH | 01 Ekim 2026 | Günlük |
| VBK · VANGUARD INDEX FUNDS | 0,03% | 1.448.225 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,03% | 664.197 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 104.878 NS | 31 Temmuz 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 464.320 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2.659.600 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 52.857 SH | 01 Ekim 2026 | Günlük |
| WSML · iShares Trust | 0,02% | 13.738 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,02% | 11.553 NS | 31 Temmuz 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,01% | 1.866 NS | 31 Temmuz 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,01% | 2.517.984 SH | 19 Ağustos 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 66.426 SH | 03 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 309.541 SH | 11 Eylül 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 151.191 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 24.505 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 41.956 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.446 NS | 31 Temmuz 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 158 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 7.025.272 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 192.148 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 19.272 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,00% | 50.502 SH | 19 Ağustos 2026 | Günlük |
| IJR · iShares Trust | · | 14.131.003 SH | 10 Eylül 2026 | Günlük |
| IJT · iShares Trust | · | 2.197.109 SH | 09 Eylül 2026 | Günlük |
| XJR · iShares Trust | · | 32.072 SH | 31 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 10.075 SH | 11 Eylül 2026 | Günlük |
ADMA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 11 analist
AL
Medyan hedef
$17.50
+80,0%
2 18,2%
Güçlü Al
7 63,6%
Al
2 18,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
4 analist · 2026-09-28Ortalama hedef $17.00 +74,9%
← Tüm hedeflerin altında
Mevcut fiyat $9.72
Düşük$12.00
Ortalama$17.00
Yüksek$21.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | · |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | · |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | · |
| VERA | · | -10.9 | · | · | -55.9% | · |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
Son Haberler Bu şirketten bahseden son manşetler
ADMA Biologics (ADMA) ASCENIV İçin FDA Etiket Genişletmesi Aldı
Yahoo Finance · 4 ay önce
ADMA Biologics (ADMA) Hakkında Analistlerin Düşünceleri Bunlar
Yahoo Finance · 4 ay, 2 hafta önce
Mizuho, ADMA Biologics Inc. (ADMA) için PT'yi 30'dan 24'e düşürdü
Yahoo Finance · 5 ay, 1 hafta önce
ADMA Biologics (ADMA), $200 Milyon Sermaye Geri Ödeme Programı Duyurdu
Yahoo Finance · 6 ay, 1 hafta önce
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
RANGE
Zarar durduruldu
risk 1
ödül 4,98
giriş
$10.86
R:R 4,98
BOUNCE_UP
Zarar durduruldu
risk 1
ödül 2,00
giriş
$18.90
R:R 2,00
Şu anda açık sinyal yok — hiçbir kart dolu değil ve bu dürüstçe.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026